1-4 of 4
Haitao Gao
Close
Sort by
Journal Articles

Induced CD25 + CD127 dim Γδ Tregs in Acute Myeloid Leukemia Suppress the Activity of Normal Αβ T Cells

Shuang Liang, Jiangying Liu, Haitao Gao, Ruoyang Liu, Ning Wu, Tianhui Dong, Xiaojun Huang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-136541
Published: 2020
Journal Articles

Influences of Mycophenolate Mofetil and Cyclosporine-a on the Ex Vivo-Expanded Vδ2 T Cells

Haitao Gao, Jiangying Liu, Xiaoyu Wang, Xiao-Jun Huang
Journal: Blood
Blood (2018) 132 (Supplement 1): 5686.
https://doi.org/10.1182/blood-2018-99-116357
Published: 2018
Journal Articles

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Keith L Davis, MA, James A. Kaye, MD DrPH, Isabelle Cote, PhD, Haitao Gao, Julian Perez Ronco, MD, Raafat Seifeldin, Pharm D, MS, PhD, Estella Mendelson, BSRN, MBA
Journal: Blood
Blood (2014) 124 (21): 1857.
https://doi.org/10.1182/blood.V124.21.1857.1857
Published: 2014
Journal Articles

Incidence of Hyperglycemia by 3 Years in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib (NIL) or Imatinib (IM) in ENESTnd

Rea Delphine, MD, PhD, Jean-francois Gautier, Massimo Breccia, Giuseppe Saglio, MD, Timothy P. Hughes, MD, MBBS, Hagop M. Kantarjian, MD, Charisse Kemp, Haitao Gao, Carmen Piccolo, MD, Richard A. Larson, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2012) 120 (21): 1686.
https://doi.org/10.1182/blood.V120.21.1686.1686
Published: 2012